Explore the top 10 low-code platforms for CIOs in 2025 that can transform application development. Discover their features, pricing, and how they can enhance your enterprise's efficiency and ...
Discover the top mobile app development tools for 2025, designed to accelerate app creation and improve user experience. From low-code solutions to comprehensive IDEs, find the right tools for your ...
No need to panic if you haven’t jumped into the crazy world of AI development yet. Find a problem to solve and get your data ...
The 10 coolest open-source software tools in 2025 include software for developing AI agentic applications, managing streams ...
The hottest big data tools in 2025 include Amazon Aurora DSQL, Snowflake Intelligence, and the Databricks Lakebase.
The bears have won out on Oracle’s stock lately, but one analyst thinks the powerful recent selloff just means more opportunity for buyers. Oracle ORCL has become a battleground stock in the months ...
Weaker-than-forecast quarterly data for Larry Ellison’s tech company shows slowdown in revenue growth and big rise in spending Business live – latest updates Oracle’s shares tumbled 15% on Thursday in ...
Oracle is aggressively building out AI data centers, most notably for OpenAI under a massive multi-year deal The company's balance sheet is already loaded with debt, and more debt is being piled on to ...
An upbeat second-quarter earnings report from Oracle wasn’t enough to shake off the artificial-intelligence jitters that have crept into the stock. Oracle ORCL cleared the bar set by Wall Street on ...
The University of Pennsylvania (Penn) has announced a new data breach after attackers stole documents containing personal information from its Oracle E-Business Suite servers in August. The private ...
Nov 28 (Reuters) - A group of banks is in talks to lend another $38 billion for Oracle (ORCL.N), opens new tab and data centre builder Vantage to fund further sites for OpenAI, the Financial Times ...
MUMBAI: Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are stepping up their ambitions. Several are now pouring capital into research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results